CX INSTITUTIONAL – SPDR S&P Pharmaceuticals ETF Transaction History
CX INSTITUTIONAL portfolio value:
$3.16M
portfolio value
CX INSTITUTIONAL quarter portfolio value change:
-4.38%
quarter
SPDR S&P Pharmaceuticals ETF 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +40982.29% | 78.68K shares | 3.16M | $40.16 | 78.87K |
| Q2 2022 | share | Increase | 0.00% | 192 shares | 8K | $42 | 192 |
| Q4 2021 | share | Decrease | -100.00% | -896 shares | -43K | $46.36 | 0 |
| Q3 2021 | share | Decrease | -97.94% | -42.68K shares | -2.21M | $47.44 | 896 |
| Q2 2021 | share | Increase | +5589.82% | 42.81K shares | 2.21M | $51.67 | 43.58K |
| Q1 2021 | share | Decrease | -58.26% | -1.06K shares | -56K | $50.17 | 766 |
| Q4 2020 | share | Decrease | -95.06% | -35.33K shares | -1.52M | $51.81 | 1.83K |
| Q3 2020 | share | Decrease | -8.34% | -3.38K shares | -127K | $43.22 | 37.16K |
| Q2 2020 | share | Increase | +60425.37% | 40.48K shares | 1.74M | $42.67 | 40.55K |
| Q1 2020 | share | Decrease | -30.21% | -29 shares | -2K | $35.76 | 67 |
| Q4 2019 | share | 0.00% | 0 shares | 1K | $45.17 | 96 | |
| Q3 2019 | share | Decrease | -44.51% | -77 shares | -4K | $35.15 | 96 |
| Q2 2019 | share | Decrease | -99.42% | -29.83K shares | -1.24M | $39.25 | 173 |
| Q1 2019 | share | Increase | +136277.27% | 29.98K shares | 1.24M | $40.9 | 30.00K |
| Q4 2018 | share | Increase | 0.00% | 22 shares | 1K | $35.96 | 22 |
| Q3 2018 | share | Decrease | -100.00% | -12.55K shares | -540K | $47.54 | 0 |
| Q2 2018 | share | Increase | 0.00% | 12.55K shares | 540K | $42.06 | 12.55K |